Discovery of the Selective KRAS G13D Inhibitors Derived from the Scaffold of KRAS G12C Inhibitor

Please copy the URL and add it into your RSS Feed Reader.

Facebook Linkedin Weibo

Download PDF

Synfacts 2024; 20(03): 0320
DOI: 10.1055/s-0043-1773092

Innovative Drug Discovery and Development

Contributor(s):

Antonia F. Stepan (Roche)

,

Seong Heon Kim (Hyundai Pharm)

KRAS G13D - GTPase - oncology - selective inhibitor - SBDD - salt bridge

Article published online:
14 February 2024

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany